This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CME Group (CME) to Introduce E-mini Nasdaq-100 Weekly Options
by Zacks Equity Research
CME Group (CME) is set to launch Weekly options on Oct 3 to add to the robust suite of Monday, Wednesday and Friday Weeklies, End-of-Month and Quarterly options.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess have been highlighted in this Industry Outlook article.
5 Securities and Exchanges to Gain From Increased Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
Why Should You Stay Invested in CME Group (CME) Stock Now?
by Zacks Equity Research
Increased volatility driving improved volumes should fuel clearing and transaction fees, improving non-transactional revenues and adequate financial flexibility bodes well for CME Group (CME).
Coinbase Global (COIN) Q2 Earnings Miss on Lower Trading Volume
by Zacks Equity Research
Coinbase (COIN) Q2 results reflect lower trading volumes in both retail and institutional as the trend of both lower crypto asset prices and volatility that began in late 2021 continued into the second quarter of 2022.
Intercontinental Exchange (ICE) Q2 Earnings Top Estimates
by Zacks Equity Research
Intercontinental Exchange (ICE) Q2 results reflect persistent revenue growth, driven by strong Exchanges and Fixed Income and Data Services and benefits of the strength of technology and data services.
Cboe Global (CBOE) Q2 Earnings Miss, Revenues Beat, View Up
by Zacks Equity Research
Cboe Global (CBOE) Q2 results reflect an increase in clearing fees and access and capacity fees, growth in European equities and clearing, and higher net transaction and clearing fees.
CME Group (CME) Q2 Earnings, Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
CME Group (CME) Q2 results reflect higher revenues and lower expenses.
CME Group (CME) Q2 Earnings Beat Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 2.60% and 0.77%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CBOE Global (CBOE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CBOE (CBOE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group (CME) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
CME Group's (CME) Q2 earnings is likely to reflect improved clearing, transaction fees and other revenues, and market data and information services, weighed on by higher expenses.
CME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) Beats on Q2 Earnings, Tightens Expense View
by Zacks Equity Research
Nasdaq (NDAQ) Q2 earnings reflect solid performance of both segments.
Here's Why American Express (AXP) Might Beat on Q2 Earnings
by Zacks Equity Research
Second-quarter results of American Express (AXP) are likely to reflect a rise in the overall spending level.
Marsh & McLennan (MMC) to Post Q2 Earnings: What to Expect?
by Zacks Equity Research
Marsh & McLennan's (MMC) second-quarter results are likely to reflect new business growth and robust retention rates.
Why Discover Financial (DFS) is Set to Beat on Q2 Earnings
by Zacks Equity Research
Discover Financial's (DFS) second-quarter results are likely to reflect improved protection products revenues.
Nasdaq (NDAQ) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Nasdaq (NDAQ) Q2 performance is likely to have benefited from the acquisition of Verafin, higher SaaS revenues, higher licensing revenues and organic revenue growth.
MarketAxess (MKTX) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
MarketAxess' (MKTX) second-quarter results are likely to be affected by higher costs and expenses.
Why CME (CME) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Hold is a Prudent Approach for CME Group (CME) Stock Now
by Zacks Equity Research
Increased volatility driving improved volumes should fuel clearing and transaction fees, improving non-transactional revenues and adequate financial flexibility bodes well for CME Group (CME).
The Zacks Analyst Blog Highlights Accenture, SAP, The Estee Lauder, CME Group, and Aon
by Zacks Equity Research
Accenture, SAP, The Estee Lauder, CME Group, and Aon are part of Zacks top Analyst Blog.
Top Analyst Reports for Accenture, SAP & The Estee Lauder
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Accenture plc (ACN), SAP SE (SAP), and The Estee Lauder Companies Inc. (EL).
Why Is CME (CME) Down 12.8% Since Last Earnings Report?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Should You Stay Invested in CME Group (CME) Stock
by Zacks Equity Research
Compelling portfolio, driving higher clearing and transaction fees, as well as improving non-transactional revenues should continue to drive CME Group (CME).
Crypto and Blockchain Get a Gut Check on Risk and Stability
by Kevin Cook
Risk management is not a science and still fully subject to the whims of human emotion and the madness of crowds.